Oregonians paying 10 times more for prescription drugs



Oregonians have been paying 10 times more for name brand prescription drugs because drug manufacturers have managed to delay production of generics.

This resulted in average delays of five years that left patients paying up to 33 times as much for brand names, according to a report released yesterday.

Some of the drugs listed include Lipitor, Tamoxifen and Cipro.